ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 104 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,572 | -27.1% | 20,909 | 0.0% | 0.00% | – |
Q2 2023 | $74,854 | +89.4% | 20,909 | +15.3% | 0.00% | – |
Q1 2023 | $39,523 | +18029.8% | 18,130 | 0.0% | 0.00% | – |
Q4 2022 | $218 | -99.8% | 18,130 | 0.0% | 0.00% | – |
Q3 2022 | $117,000 | +41.0% | 18,130 | 0.0% | 0.00% | – |
Q2 2022 | $83,000 | -97.0% | 18,130 | -94.4% | 0.00% | – |
Q1 2022 | $2,778,000 | -20.7% | 321,159 | +30.9% | 0.00% | – |
Q4 2021 | $3,503,000 | -35.5% | 245,345 | -0.7% | 0.00% | -100.0% |
Q3 2021 | $5,428,000 | +86.4% | 246,971 | +13.4% | 0.00% | – |
Q2 2021 | $2,912,000 | +1593.0% | 217,708 | +1183.9% | 0.00% | – |
Q1 2021 | $172,000 | +142.3% | 16,957 | 0.0% | 0.00% | – |
Q4 2020 | $71,000 | +61.4% | 16,957 | 0.0% | 0.00% | – |
Q3 2020 | $44,000 | -25.4% | 16,957 | 0.0% | 0.00% | – |
Q2 2020 | $59,000 | +15.7% | 16,957 | 0.0% | 0.00% | – |
Q1 2020 | $51,000 | -70.7% | 16,957 | -50.0% | 0.00% | – |
Q4 2019 | $174,000 | +222.2% | 33,914 | +100.0% | 0.00% | – |
Q3 2019 | $54,000 | -10.0% | 16,957 | 0.0% | 0.00% | – |
Q2 2019 | $60,000 | – | 16,957 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |